Morphogens and growth factor signalling in the myeloma bone-lining niche
Multiple myeloma is a malignancy caused by the clonal expansion of abnormal plasma cells. Myeloma cells have proven to be incredibly successful at manipulating their microenvironment to promote growth and to evade modern therapies. They have evolved to utilise the integral signalling pathways of the...
Principais autores: | Morris, EV, Edwards, CM |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Springer
2021
|
Registros relacionados
-
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
por: Gooding, S, et al.
Publicado em: (2019) -
PB2082: BONE MORPHOGENIC PROTEIN-6 PROMOTES THE PROLIFERATION AND INHIBITS APOPTOSIS IN MULTIPLE MYELOMA
por: Jiaqi Fu, et al.
Publicado em: (2023-08-01) -
Myeloma and marrow adiposity: Unanswered questions and future directions
por: Morris, EV, et al.
Publicado em: (2021) -
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
por: Gámez, B, et al.
Publicado em: (2021) -
Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction
por: Hayley M. Sabol, et al.
Publicado em: (2022-06-01)